Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-25-002844
Filing Date
2025-01-17
Accepted
2025-01-21 09:24:21
Documents
122

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 3467082
2 ex5-1.htm EX-5.1 29465
3 ex23-1.htm EX-23.1 4379
4 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 34381
5 forms-1_001.jpg GRAPHIC 4045
6 forms-1_002.jpg GRAPHIC 3121
7 ex5-1_001.jpg GRAPHIC 3741
  Complete submission text file 0001493152-25-002844.txt   13399711

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE bfri-20240930.xsd EX-101.SCH 96018
9 XBRL CALCULATION FILE bfri-20240930_cal.xml EX-101.CAL 115065
10 XBRL DEFINITION FILE bfri-20240930_def.xml EX-101.DEF 396230
11 XBRL LABEL FILE bfri-20240930_lab.xml EX-101.LAB 651910
12 XBRL PRESENTATION FILE bfri-20240930_pre.xml EX-101.PRE 559894
125 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 2096415
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-284371 | Film No.: 25540797
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)